SCHEMBL5340310

SCHEMBL5340310

OCCCCc1nn(Cc2ccc(Cl)cc2Cl)c2cc(OC(F)(F)F)ccc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 1/20 0.40
NPSR1 Q6W5P4 2/20 0.39
CYP1A2 P05177 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP2D6 P10635 2/20 0.39
CYP2C9 P11712 2/20 0.39
TSHR P16473 1/20 0.39
PMP22 Q01453 1/20 0.39
HIF1A Q16665 1/20 0.39
EPHX2 P34913 2/20 0.37
F2RL3 Q96RI0 4/20 0.37
LMNA P02545 1/20 0.36
USP2 O75604 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
PPARG P37231 2/20 0.36
NPC1 O15118 1/20 0.35
SLC16A3 O15427 2/20 0.35
SLC16A1 P53985 2/20 0.35
MCTS1 Q9ULC4 2/20 0.35
SLC9A1 P19634 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5334131 0.99 TRPV1 (0.40) TRPV1NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL5317597 0.97 TRPV1 (0.41) TRPV1NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL5323336 0.93 TRPV1 (0.42) TRPV1NPSR1CYP1A2CYP3A4CYP2D6
SCHEMBL5339999 0.91 F2RL3 (0.38) CYP1A2CYP3A4CYP2D6CYP2C9F2RL3
SCHEMBL5373644 0.91 NR1H2 (0.38) TRPV1CYP2D6CYP2C9F2RL3PPARG
SCHEMBL5338753 0.91 PPARG (0.36) TRPV1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5343398 0.91 F2RL3 (0.38) CYP1A2CYP3A4CYP2D6CYP2C9F2RL3
SCHEMBL5383568 0.91 NR1H2 (0.38) TRPV1CYP2D6CYP2C9F2RL3PPARG
SCHEMBL5346874 0.90 PPARG (0.36) TRPV1CYP1A2CYP3A4CYP2D6CYP2C9
SCHEMBL5320785 0.89 F2RL3 (0.43) TRPV1NPSR1CYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1786424-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT The University of Kansas (US) 2007-05-23 EP claimed
WO-2006023704-A2 LONIDAMINE ANALOGUES AND THEIR USE IN MALE CONTRACEPTION AND CANCER TREATMENT UNIVERSITY OF KANSAS (US) 2006-03-02 WO claimed